GS-626510 is a potent BET family bromodomains inhibitor. It acts by targeting BRD2/3/4, and BRDT.
For research use only. We do not sell to patients.
Name | GS-626510 |
---|---|
Iupac Chemical Name | 4-(2-Cyclopropyl-7-(6-methylquinolin-5-yl)-1H-benzo[d]imidazol-5-yl)-3,5-dimethylisoxazole |
Synonyms | GS-626510; GS 626510; GS626510; |
Molecular Formula | C25H22N4O |
Molecular Weight | 394.47 |
Smile | CC1=C(C2=CC(C3=C4C=CC=NC4=CC=C3C)=C5NC(C6CC6)=NC5=C2)C(C)=NO1 |
InChiKey | KHQQNXFBTALTQF-UHFFFAOYSA-N |
InChi | InChI=1S/C25H22N4O/c1-13-6-9-20-18(5-4-10-26-20)22(13)19-11-17(23-14(2)29-30-15(23)3)12-21-24(19)28-25(27-21)16-7-8-16/h4-6,9-12,16H,7-8H2,1-3H3,(H,27,28) |
CAS Number | 1637770-13-8 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid to white solid |
---|---|
Purity | >98% |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |